News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- May 01, 2018
May is Lupus Awareness Month, sponsored by organizations like Lupus Foundation of America, Lupus LA, and The Lupus Research Alliance. DxTerity is proud to support these organizations in advancing...
- Apr 30, 2018
This May 1 and May 2, 2018, the Young Jewish Professionals Organization is hosting its annual CEO Healthcare Symposium in New York City, NY, and Bob Terbrueggen, DxTerity Founder & CEO, will be...
- Mar 29, 2018Total revenues of $37.5 million for the fiscal year 2017 compared to $22.4 million for the fiscal year 2016.
Dallas, TX, March 29, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year...
- Mar 29, 2018
The following tables provide a reconciliation of SWK’s reported (GAAP) income before provision for income tax to SWK’s adjusted net income attributable to SWK Holdings Corporation stockholders...
- Mar 15, 2018Total revenues of $6.8 million for the first quarter of 2018 compared to $14.9 million for the first quarter of 2017.
Dallas, TX, May 14, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2018 financial results.
- Jan 17, 2018
The Precision Medicine World Conference (PMWC) 2018 will take place in Silicon Valley on January 22-24, 2018. This year, we’re excited to announce that DxTerity Founder & CEO Bob Terbrueggen...
- Nov 10, 2017Total revenues of approximately $5.5 million for the third quarter of 2017 compared to $4.2 million for the third quarter of 2016.
Dallas, TX, November 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2017 financial...
- Nov 05, 2017
DxTerity, a patient-centric genomics company developing at-home genomic monitoring blood tests for immune mediated diseases, today announced that data on the BRAVO Study in which participants with...
- Sep 21, 2017
DxTerity announced today that it is collaborating with the City of Hope Medical Center on the clinical development of a blood test that could possibly predict whether cancer patients about to...
- Aug 14, 2017Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016.
Dallas, TX, August 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2017 financial...